Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Bio-Techne Corp

Symbol: TECH     Sector: Healthcare     Industry: Biotechnology

Dividend Yield
0.61%
Current Price
$210.59
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
184,861,000
184,861,000
60,251,000
124,610,000
80,520,000
44,090,000
44,654,000
423,433,000
1,872,618,000
726,352,000
-
-
12,500,000
178,790,000
522,265,000
-
-
 
15,552,000

Financials 2018

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
174,510,000
174,510,000
61,492,000
113,018,000
79,415,000
33,603,000
17,556,000
379,934,000
1,844,832,000
748,407,000
1,096,425,000
85,886,000
12,500,000
156,533,000
545,369,000
-8,278,000
46,563,000
 
15,812,000

Q 3

2018-09-30
162,970,000
162,970,000
55,367,000
107,603,000
81,840,000
25,763,000
17,403,000
383,112,000
1,872,198,000
762,729,000
1,109,469,000
94,674,000
12,500,000
163,721,000
561,473,000
-26,134,000
39,448,000
 
14,789,000

Q 2

2018-06-30
180,254,000
180,254,000
58,073,000
122,181,000
79,266,000
42,915,000
41,701,000
398,366,000
1,593,202,000
514,141,000
1,079,061,000
121,990,000
-
181,754,000
-
39,975,000
64,839,000
 
13,979,000

Q 1

2018-03-31
163,973,000
163,973,000
53,712,000
110,261,000
67,177,000
43,084,000
19,738,000
393,504,000
1,617,808,000
559,516,000
1,058,292,000
86,608,000
-
176,434,000
-
-37,232,000
21,650,000
 
13,892,000

Financials 2017

Update: 2019-06-11 03:40:02

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
154,153,000
154,153,000
52,319,000
101,834,000
77,686,000
24,148,000
48,847,000
346,086,000
1,555,422,000
557,603,000
997,819,000
121,458,000
-
162,385,000
-
48,387,000
39,182,000
 
13,911,000